Both in Pharmaceuticals
Braveheart Bio vs Trevi Therapeutics
Over the past year BRVE returned −19.3% and TRVI returned −14.7%; their daily moves had a correlation of 0.33.
BRVE −19.3% TRVI −14.7%Growth of $1, one year, split-adjusted
| Metric | BRVE | TRVI |
|---|---|---|
| Price | $21.51 | $13.56 |
| Market cap | $1.94B | $1.93B |
| Today | +1.51% | −1.81% |
| 1 month | +0.5% | −4.4% |
| 6 months | — | −2.2% |
| Year to date | — | +8.3% |
| 1 year | — | +28.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $318.9M |
| Dividend yield | — | — |
| Volatility (60d) | — | 39.6% |
| Short % of float | 10.9% | 14.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).